
“All three of them.”
A year ago, a single genetic test changed everything — it named Shwachman-Diamond Syndrome in all three of our children. There is no approved cure.
A focused effort to turn breakthrough gene-editing and stem-cell science into real hope — for our three children, Abigail (9), Dan (6), and Ben (2), and every child living with SDS.
A year ago, one genetic test changed everything. This is what we did next.

A year ago, a single genetic test changed everything — it named Shwachman-Diamond Syndrome in all three of our children. There is no approved cure.

Gene editing can now target SDS at its source. After decades of “monitor and wait,” a cure is no longer a fantasy — the only gap left is execution, funding, and speed.

We started Rewrite SDS to fund speed — to bring that cure to Abigail (9), Dan (6), and Ben (2), and every child living with SDS.
Shwachman-Diamond Syndrome is a rare, inherited genetic disorder caused by a change in the SBDS gene. It affects several systems of the body at once — and today, no approved therapy corrects the disease itself.
The marrow struggles to produce enough healthy blood cells.
Low white-cell counts leave children far more vulnerable to infection.
Many children are small for their age and grow more slowly.
The pancreas often can’t release the enzymes needed to absorb food.
SDS carries a serious lifelong risk of blood cancer.
Constant blood tests, bone-marrow checks, and dozens of specialists.
SDS sits inside a vast, underfunded frontier — where science has finally caught up to the need.
We direct support toward the highest-leverage work that shortens the path from discovery to treatment for SDS:
We support promising, credible science aimed at the root cause. We do not present any single program as guaranteed — our role is to help the best work move faster.
Many organizations support the broader SDS field. Our role is narrower: to help accelerate the most promising cure-directed work — and to back it directly.
Rather than spread support thinly across the field, we focus everything behind the most promising root-cause approach to curing SDS.
Directed, milestone-based grants to the specific program doing the work — so dollars reach the bench, not general overhead.
Small and family-led, we can decide quickly and take a focused, well-judged risk that a larger body can’t.
The science is becoming actionable, and how fast we get there now depends on partnership.
Support research and translational programs advancing treatments and a cure for SDS.
Get in touch →Contribute expertise in science, medicine, biotech, fundraising, operations, or communications.
Get in touch →Introduce researchers, foundations, philanthropists, and partners who can accelerate progress.
Get in touch →Whether your support is a gift, an introduction, or your expertise, you become part of a community working toward a future where SDS no longer defines a child’s life.